These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2780779)

  • 1. Dissociation of naloxone-sensitive and naloxone-insensitive effects of U-50,488H.
    Young GA
    Pharmacol Biochem Behav; 1989 May; 33(1):215-7. PubMed ID: 2780779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol pretreatment unmasks the kappa opioid effects of U-50, 488H on cortical EEG and EEG power spectra in rats.
    Young GA; Marquis KL; Paquette NC; Gussio RP; Khazan N
    Neuropharmacology; 1989 Aug; 28(8):881-4. PubMed ID: 2550842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between U-50,488H and sigma receptor antagonists: EEG, EEG power spectral and behavioral correlates.
    Young GA; Hudson GM; Stamidis H; Steinfels GF
    Eur J Pharmacol; 1993 Feb; 231(3):473-6. PubMed ID: 8095467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of kappa-opioid agonist U-50, 488H on wet-dog shaking behavior induced by hippocampal stimulation in rats.
    Ohno M; Yamamoto T; Araki H; Ueki S
    Psychopharmacology (Berl); 1987; 91(2):189-92. PubMed ID: 3107029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between kappa-opioid agonist, U-50, 488H, and kainic acid: behavioral and histological assessments.
    Lason W; Simpson JN; McGinty JF
    Brain Res; 1989 Mar; 482(2):333-9. PubMed ID: 2539886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential tolerance to repeated daily injections of N-allylnormetazocine and its enantiomers in the rat.
    Young GA; Hong O; Khazan N
    Neuropharmacology; 1987 May; 26(5):463-7. PubMed ID: 3037416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Eur J Pharmacol; 1992 Feb; 212(1):15-9. PubMed ID: 1555635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level.
    Alcaraz C; Milanés MV; Vargas ML
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1385-9. PubMed ID: 8396634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stimulation of central kappa opioid receptors decreases male sexual behavior and locomotor activity.
    Leyton M; Stewart J
    Brain Res; 1992 Oct; 594(1):56-74. PubMed ID: 1334765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
    Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
    Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.
    Kamei J; Tanihara H; Kasuya Y
    Eur J Pharmacol; 1990 Oct; 187(2):281-6. PubMed ID: 2272363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
    Bileviciute-Ljungar I; Spetea M
    Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of opiate agonist and antagonist in myocardial ischaemia suggest a role of endogenous opioid peptides in ischaemic heart disease.
    Lee AY; Chen YT; Kan MN; P'eng FK; Chai CY; Kuo JS
    Cardiovasc Res; 1992 Apr; 26(4):392-5. PubMed ID: 1638574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1990 Jul; 254(1):8-12. PubMed ID: 2164102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA; Romanelli L; Amico MC; Valeri P
    Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalographic and behavioral effects of D-ala2-methionine-enkephalinamide and morphine in the rat.
    Tortella FC; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1978 Sep; 206(3):636-43. PubMed ID: 702326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa opiate receptor agonists: effects on behavior and on brain function and structure in rhesus monkeys.
    Heath RG; Fitzjarrell AT; Walker CF
    Biol Psychiatry; 1984 Jul; 19(7):1045-74. PubMed ID: 6089918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
    Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
    Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.